View the entire issue.
A new business coalition backed by PhRMA and the Biotechnology Industry Organization is calling on the Obama administration to pressure India to end trade practices it says discriminate against foreign pharmaceutical companies and discourage U.S. drug exports.
Pharma gaints Johnson & Johnson, AstraZeneca and Teva have all made moves this month on disease-specific pharmaceutical acquisitions as the industry looks to compete with booming biotechs and specialty pharma companies through cautious portfolio expansion.
The FDA will hold a public meeting at its Maryland headquarters next month to gather the public’s input on how to shape its new legislative authorities over commercial drug importers.
A House Republican has introduced draft legislation clarifying existing FDA authority over compounding pharmacies but eschewing new regulatory powers included in a bipartisan Senate bill.
Amicus Therapeutics says it is holding off filing an NDA for its orphan drug Amigal to treat Fabry disease until it analyzes data from a second Phase III study as recommended by the FDA.